Widespread image reuse, manipulation uncovered in animal studies of brain injury 

One of the papers in the analysis contained a figure (bottom) found to have overlap with other work by the same author (top). Both papers have been retracted.
Annotated images: PubPeer

More than 200 papers on ways to prevent brain injury after a stroke contain problematic images, according to an analysis published today in PLOS Biology. Researchers found dozens of duplicated Western blots and reused images of tissues and cells purportedly showing different experimental conditions — both within a single paper and across separate publications.

As we reported last year, René Aquarius and Kim Wever, of the Radboud University Medical Center in the Netherlands, first noticed these patterns in 2023 when they started working on a systematic review of animal studies in the field. They had wanted to identify promising interventions for preventing early brain injury following hemorrhagic stroke. Instead, their efforts turned into an audit of suspicious papers in their field. 

Of the 608 studies they analyzed, more than 240, or 40 percent, contained problematic images. So far, 19 of those articles have been retracted and 55 corrected, mostly from the researchers’ efforts to alert journals and publishers about the issues. Almost 90 percent of the problematic papers had a corresponding author based in China, and many appeared in major journals such as Stroke, Brain Research and Molecular Neurobiology. 

Continue reading Widespread image reuse, manipulation uncovered in animal studies of brain injury 

A shadow was cast on a bone researcher’s work. What are journals doing about his papers?

Last year, a researcher cast doubt on a bone scientist’s clinical trials, suggesting some of the findings may not be legitimate. So what’s happened since?

Since 2015, journals have retracted 14 papers by bone researcher Yoshihiro Sato, based at Mitate Hospital in Japan, for issues ranging from self-plagiarism, to problems with data, to including co-authors without their consent. (We covered the latest two retractions this week.) Last year’s analysis identified patterns in more than 30 of Sato’s clinical trials that suggest systematic problems with the results. (Sato has defended his research.)

With doubts cast on Sato’s body of work, we contacted the journals that have published his papers involving human trials, to see if any taken another look at Sato’s work; several responded. While most believe there is little reason to take further action at this time, some told us they are investigating.
Continue reading A shadow was cast on a bone researcher’s work. What are journals doing about his papers?